201 related articles for article (PubMed ID: 6389940)
1. [Studies on prostate specific antigen, gamma-seminoprotein (gamma-Sm) as a tumor marker of prostatic cancer].
Kamachi S; Sakurabayashi I; Kawai T
Rinsho Byori; 1984 Jul; 32(7):781-5. PubMed ID: 6389940
[No Abstract] [Full Text] [Related]
2. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
[TBL] [Abstract][Full Text] [Related]
3. [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein].
Shinoda I
Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2627-39. PubMed ID: 1703555
[TBL] [Abstract][Full Text] [Related]
4. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers].
Yamaguchi K; Tanaka M; Kitagawa N; Kotake T; Yanagi S; Ito H
Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006
[TBL] [Abstract][Full Text] [Related]
5. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
Yoshiki T; Okada K; Oishi K; Yoshida O
Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer].
Arai Y; Yoshki T; Okada K; Yoshida O; Yamamoto N; Sakatoku J; Sugimura Y; Kawamura J
Hinyokika Kiyo; 1989 Sep; 35(9):1519-28. PubMed ID: 2479237
[TBL] [Abstract][Full Text] [Related]
8. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
Akimoto S; Akakura K; Masai M; Isaka S; Shimazaki J
Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
[TBL] [Abstract][Full Text] [Related]
9. [Benign prostatic hypertrophy with high levels of gamma-seminoprotein (gamma-Sm), prostate specific antigen: report of two cases].
Asakawa M; Yasumoto R; Kamizuru M; Maekawa M
Hinyokika Kiyo; 1988 Dec; 34(12):2189-91. PubMed ID: 2467544
[TBL] [Abstract][Full Text] [Related]
10. [Prostate specific antigen in serum of the patients with prostatic cancer].
Akimoto S; Akakura K; Fuse H; Shimazaki J
Hinyokika Kiyo; 1988 Apr; 34(4):636-42. PubMed ID: 2456678
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
Sakai N; Ogawa T; Ishibashi Y; Fukuoka H; Sakanishi S
Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural localizations of beta-microseminoprotein, a prostate-specific antigen, in human prostate and sperm: comparison with gamma-seminoprotein, another prostate-specific antigen.
Ito Y; Tsuda R; Kimura H
J Lab Clin Med; 1989 Sep; 114(3):272-7. PubMed ID: 2475560
[TBL] [Abstract][Full Text] [Related]
13. [Clinical studies of gamma-seminoprotein in prostatic disease. II. Immunohistochemical study of gamma-seminoprotein].
Nakashima J; Hasegawa S; Nakashima Y; Nakamura S; Kimura S; Tachibana M; Deguchi N; Tazaki H
Hinyokika Kiyo; 1987 Dec; 33(12):2059-63. PubMed ID: 3329454
[TBL] [Abstract][Full Text] [Related]
14. Serum gamma-seminoprotein determination in prostatic cancer.
Shimazaki J; Akimoto S; Akakura K; Yoshiki T; Yoshida O; Okada K; Matsuoka K; Noda S; Eto K
Hinyokika Kiyo; 1991 Apr; 37(4):341-7. PubMed ID: 1716404
[TBL] [Abstract][Full Text] [Related]
15. [Immunochemical localization of gamma-seminoprotein and beta-microseminoprotein in prostatic glands--forensic immunological studies of body fluids and secretion: report XIX].
Tsuda R; Hara M; Inoue T; Okabe T
Nihon Hoigaku Zasshi; 1983 Feb; 37(1):16-9. PubMed ID: 6202907
[No Abstract] [Full Text] [Related]
16. [The measurement of serum prostatic antigens (gamma-Seminoprotein and beta-Microseminoprotein by radioimmunoassay].
Okabe T; Eto K
Igaku Kenkyu; 1982 Oct; 52(3):140-3. PubMed ID: 6190342
[No Abstract] [Full Text] [Related]
17. [Clinical evaluation of serum gamma-seminoprotein in patients with prostatic cancer].
Ishihara Y; Hiromoto Y; Higaki Y; Imamura K
Hinyokika Kiyo; 1989 Mar; 35(3):409-13. PubMed ID: 2660507
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer].
Park YC; Kiwamoto H; Nishioka T; Tsujihashi H; Mitsubayashi S; Matsuura T; Akiyama T; Kurita T; Miyamoto T
Hinyokika Kiyo; 1987 Jun; 33(6):883-8. PubMed ID: 2445188
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between reactivation and tumor markers in prostatic cancer].
Fuse H; Umeda K; Kazama T; Sakamoto M; Sakai T; Fujishiro Y; Mizuno I; Katayama T
Hinyokika Kiyo; 1991 Jan; 37(1):39-43. PubMed ID: 1707217
[TBL] [Abstract][Full Text] [Related]
20. [Clinical studies of gamma-seminoprotein in prostatic disease. I. Clinical evaluation of serum gamma-seminoprotein].
Hasegawa S; Nakashima J; Nakashima Y; Nakamura S; Kimura S
Hinyokika Kiyo; 1987 Dec; 33(12):2055-8. PubMed ID: 3329453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
